Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
| 33.50 Delayed Data As of 3:59pm ET |  -3.24 / -8.82%Today’s Change | 26.81 Today|||52-Week Range 56.25 | -17.41% Year-to-Date |
Latest ARWR News | Press Releases
No recent news for Arrowhead Pharmaceuticals Inc.
Today’s Trading
| Previous close | 36.74 |
| Today’s open | 35.37 |
| Day’s range | 32.25 - 35.60 |
| Volume | 57,879 |
| Average volume (3 months) | 938,981 |
| Market cap | $3.9B |
Data as of 3:59pm ET, 02/06/2023
Growth & Valuation
| Earnings growth (last year) | -23.01% |
| Earnings growth (this year) | -8.55% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +75.89% |
| P/E ratio | NM |
| Price/Sales | 14.33 |
| Price/Book | 9.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZLABZai Lab Ltd | -1.09 | -2.72% |
| NTLAIntellia Therapeutic... | +0.61 | +1.41% |
| DNLIDenali Therapeutics ... | -0.32 | -1.01% |
| CRSPCRISPR Therapeutics ... | +0.24 | +0.43% |
Data as of 4:00pm ET, 02/06/2023
Financials
| Next reporting date | February 7, 2023 |
| EPS forecast (this quarter) | $0.37 |
| Annual revenue (last year) | $243.2M |
| Annual profit (last year) | -$176.1M |
| Net profit margin | -72.39% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Pasadena, California |
Forecasts
